China Universal Asset Management Company’s Crinetics Pharmaceuticals CRNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$541K Buy
2025
Q1
$626K Sell
2024
Q4
$1.01M Buy
2024
Q3
$787K Buy
2024
Q2
$415K Sell
2024
Q1
$626K Buy
2023
Q4
$275K Buy
2023
Q3
$41.7K Buy
2023
Q2
$12.8K Sell
2023
Q1
$11.7K Buy
2022
Q4
$10K Buy
2022
Q3
$10K Buy